Pubblicazioni scientifiche

Candotto, V; Pezzetti, F; Bignozzi, C A; Agazzi, A; Spadari, F; Palmieri, A, Anti-tumor properties of silver, «JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS», 2019, 33, pp. 7 - 13 [Articolo in rivista]

Lauritano D.; Lucchese A.; Di Stasio D.; Vella F.D.; Cura F.; Palmieri A.; Carinci F., Molecular aspects of drug-induced gingival overgrowth: An in vitro study on amlodipine and gingival fibroblasts, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2019, 20, pp. 1 - 8 [Articolo in rivista] Open Access

Lauritano, D.; Carinci, F.; Palmieri, A.; Cura, F.; Caruso, S.; Candotto, V., Reuterinos® as adjuvant for peri-implant treatment: A pilot study, «INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY», 2019, 33, pp. 1 - 6 [Articolo in rivista]

Gatti, M.; Raschi, E.; De Ponti, F., Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: Insight from a pharmacovigilance study, «BMC PHARMACOLOGY & TOXICOLOGY», 2019, 20, pp. 1 - 10 [Articolo in rivista] Open Access

Raschi E.; De Ponti F., Strategies for early prediction and timely recognition of drug-induced liver injury: The case of cyclin-dependent kinase 4/6 inhibitors, «FRONTIERS IN PHARMACOLOGY», 2019, 10, pp. 1 - 15 [Articolo in rivista] Open Access

Fadini G.P.; Sarangdhar M.; De Ponti F.; Avogaro A.; Raschi E., Pharmacovigilance assessment of the association between Fournier's gangrene and other severe genital adverse events with SGLT-2 inhibitors, «BMJ OPEN DIABETES RESEARCH AND CARE», 2019, 7, pp. 1 - 8 [Articolo in rivista] Open Access

Raschi E.; Bianchin M.; Gatti M.; Squizzato A.; De Ponti F., Comparative Effectiveness and Safety of Direct Oral Anticoagulants: Overview of Systematic Reviews, «DRUG SAFETY», 2019, 42, pp. 1409 - 1422 [Articolo in rivista]

Raschi, E.; Mazzarella, A.; Antonazzo, I. C.; Bendinelli, N.; Forcesi, E.; Tuccori, M.; Moretti, U.; Poluzzi, E.; De Ponti, F., Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System, «TARGETED ONCOLOGY», 2019, 14, pp. 205 - 221 [Articolo in rivista] Open Access

Raschi, E.; Poluzzi, E.; Marchesini, G.; De Ponti, F., Dapagliflozin and cardiovascular outcomes: anything else to DECLARE?, «EXPERT OPINION ON PHARMACOTHERAPY», 2019, 20, pp. 1087 - 1090 [Articolo in rivista] Open Access

Bove M, Cicero AFG, Borghi C, Emerging drugs for the treatment of hypercholesterolemia, «EXPERT OPINION ON EMERGING DRUGS», 2019, 24, pp. 63 - 69 [Articolo in rivista]

Cosentino, Er; Landolfo, M; Bentivenga, C; Spinardi, L; Esposti, Dd; Cicero, Af; Miceli, R; Bui, V; Berardi, E; Borghi, C, Morbidity and mortality in a population of patients affected by heart failure and chronic obstructive pulmonary disease: an observational study., «BMC CARDIOVASCULAR DISORDERS», 2019, 19, pp. 20 - 26 [Articolo in rivista] Open Access

Edoardo Picetti, Sandra Rossi, Fikri M. Abu-Zidan, Luca Ansaloni, Rocco Armonda, Gian Luca Baiocchi, Miklosh Bala, Zsolt J. Balogh, Maurizio Berardino, Walter L. Biffl, Pierre Bouzat, Andras Buki, Marco Ceresoli, Randall M. Chesnut, Osvaldo Chiara, Giuseppe Citerio, Federico Coccolini, Raul Coimbra, Salomone Di Saverio, Gustavo P. Fraga, Deepak Gupta, Raimund Helbok, Peter J. Hutchinson, Andrew W. Kirkpatrick, Takahiro Kinoshita, Yoram Kluger, Ari Leppaniemi, Andrew I. R. Maas, Ronald V. Maier, Francesco Minardi, Ernest E. Moore, John A. Myburgh, David O. Okonkwo, Yasuhiro Otomo, Sandro Rizoli, Andres M. Rubiano, Juan Sahuquillo, Massimo Sartelli, Thomas M. Scalea, Franco Servadei, Philip F. Stahel, Nino Stocchetti, Fabio S. Taccone, Tommaso Tonetti, George Velmahos, Dieter Weber, Fausto Catena, WSES consensus conference guidelines: Monitoring and management of severe adult traumatic brain injury patients with polytrauma in the first 24 hours, «WORLD JOURNAL OF EMERGENCY SURGERY», 2019, 14, pp. 1 - 9 [Articolo in rivista] Open Access

Borghi, C; Fogacci, F; Cicero, ARRIGO FRANCESCO GIUSEPPE, Cardiovascular Risk Reduction with Icosapent Ethyl., «THE NEW ENGLAND JOURNAL OF MEDICINE», 2019, 380, pp. 1677 - 1678 [Articolo in rivista]

Strilchuk L, Fogacci F, Cicero AF, Safety and tolerability of injectable lipid-lowering drugs: an update of clinical data., «EXPERT OPINION ON DRUG SAFETY», 2019, 18, pp. 611 - 621 [Articolo in rivista]

Strilchuk L, Fogacci F, Cicero AF, Safety and tolerability of available urate-lowering drugs: a critical review, «EXPERT OPINION ON DRUG SAFETY», 2019, 18, pp. 261 - 271 [Articolo in rivista]

Presta V, Figliuzzi I, Miceli F1, Coluccia R, Fogacci F, Cicero AFG, Ferrucci A, Borghi C, Volpe M, Tocci G; EFFECTUS Steering Committee., Achievement of low density lipoprotein (LDL) cholesterol targets in primary and secondary prevention: Analysis of a large real practice database in Italy., «ATHEROSCLEROSIS», 2019, 285, pp. 40 - 48 [Articolo in rivista]

Derosa G, Cicero AFG, D'Angelo A, Maffioli P, Ascophyllum nodosum and Fucus vesiculosus on glycemic status and on endothelial damage markers in dysglicemic patients., «PHYTOTHERAPY RESEARCH», 2019, 33, pp. 791 - 797 [Articolo in rivista]

MA Calverley, Peter; Page, Clive; W Dal Negro, Roberto; Fontana, Giovanni; Cazzola, Mario; Cicero, ARRIGO FRANCESCO GIUSEPPE; Pozzi, Edoardo; A Wedzicha, Jadwiga, Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation, «INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE», 2019, 14, pp. 2733 - 2744 [Articolo in rivista] Open Access

De Cassai, Alessandro; Tonetti, Tommaso, Central venous line placement and ultrasound probe damage: A word of caution, «JOURNAL OF MEDICAL ULTRASOUND», 2019, 27, pp. 110 - 110 [Replica/breve intervento (e simili)] Open Access

Giuseppa Castellino, Dragana Nikolic, Antonio Magán-Fernández, Giuseppe Antonio Malfa, Roberta Chianetta, Angelo M. Patti, Antonella Amato, Giuseppe Montalto, Peter P. Toth, Maciej Banach, Arrigo F. G. Cicero, Manfredi Rizzo, Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study., «NUTRIENTS», 2019, 11, pp. 1 - 17 [Articolo in rivista] Open Access